Cystadenocarcinoma, Mucinous - 25 Studies Found Status Study Withdrawn Study Name: Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy Condition: Fatigue Malignant Ovarian Mixed Epithelial Tumor Neuropath Date: 2011-12-14 Interventions: Dietary Supplement: Acetyl-L-Carnitine Hydrochloride Active, not recruiting Study Name: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy Condition: Cognitive Side Effects of Cancer Therapy Malignant Ovarian Epithelial Tumor Procedure: Cognitive Assessment Active, not recruiting Study Name: Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Condition: Fallopian Tube Clear Cell Adenocarcinoma Fallopian Tube Endometrioid Adenocarcinoma Date: 2010-02-23 Interventions: Drug: Bortezomib Given IP Completed Study Name: Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer Condition: Chemotherapeutic Agent Toxicity Endometrial Adenocarcinoma Date: 2008-12-20 Interventions: Drug: Paclitaxel Given IV or i Completed Study Name: Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) Condition: Brenner Tumor Fallopian Tube Cancer Ovarian Carcinosarcoma Date: 2004-06-10 Interventions: Drug: carboplatin Given intrap <<< Previous